Holly Barker is a freelance writer specializing in biology, medicine and psychology. She has a Ph.D. in clinical neuroscience from King’s College London in the United Kingdom and a B.Sc. degree in biochemistry from the University of Manchester. She has previously written for Discover and BioNews. She is based in London.
Holly Barker
Contributing writer
From this contributor
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.
Constellation of studies charts brain development, offers ‘dramatic revision’
Protein tug-of-war controls pace of synaptic development, sets human brains apart
Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.
Protein tug-of-war controls pace of synaptic development, sets human brains apart
Worms help untangle brain structure/function mystery
The synaptic connectome of most animals bears little resemblance to functional brain maps, but it can still predict neuronal activity, according to two preprints that tackle the puzzle in C. elegans.
Worms help untangle brain structure/function mystery
Oxytocin prompts prairie voles to oust outsiders, fortifying their friendships
The “love hormone” drives the neurobiology behind platonic bonds in animals usually studied for their romantic attachments.
Oxytocin prompts prairie voles to oust outsiders, fortifying their friendships
Genetic background steers PTEN syndrome traits
People with the syndrome, caused by variants in the gene PTEN, often have autism or cancer, or both, but it depends on the genetic diversity encoded in the components of distinct cell signaling pathways, according to a new study.
Explore more from The Transmitter
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.